| Authors: |
Alsulami RA; R.A. Alsulami, MD, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Chugani B; B. Chugani, MSc, Division of Clinical Pharmacology & Toxicology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada., Johnstone J; J. Johnstone, MN, Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Yeh EA; E.A. Yeh, MD, MA, Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Yeung RSM; R.S.M. Yeung, MD, PhD, Division of Rheumatology, Department of Pediatrics, The Hospital for Sick Children and Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Loeff FC; F.C. Loeff, PhD, Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, the Netherlands., Hiraki LT; L.T. Hiraki, MD, ScD, Division of Rheumatology, Department of Pediatrics, The Hospital for Sick Children and Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Knight AM; A.M. Knight, MD, MSCE, Division of Rheumatology, Department of Pediatrics, The Hospital for Sick Children and Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Levy DM; D.M. Levy, MD, MS, Division of Rheumatology, Department of Pediatrics, The Hospital for Sick Children and Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Verstegen RHJ; R.H.J. Verstegen, MD, PhD, Division of Clinical Pharmacology & Toxicology and Division of Rheumatology, Department of Pediatrics, The Hospital for Sick Children and Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada. |
